SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

HUTCHMED (China) Limited HCM NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • HK • USD

SharesGrow Score

SharesGrow Intrinsic Value

Analyst Price Target

HUTCHMED (China) Limited (HCM) 有 12 个已识别的同行可供比较在 Healthcare 板块. 同行包括 ALKS, ANIP, COLL, DCPH, EGRX, IRWD 等.

HCM 的市值为 $2.67B, 而同行平均市值为 $3.85B.

同行与相似公司 — HCM

$33.22 -1.92% $5.54B

ANI Pharmaceuticals, Inc.

$76.48 -2.31% $1.71B

Collegium Pharmaceutical, Inc.

$34.93 -1.99% $1.11B

Deciphera Pharmaceuticals, Inc.

$25.59 +0.08% $2.21B

Eagle Pharmaceuticals, Inc.

$0.09 -75.08% $1.1M

Ironwood Pharmaceuticals, Inc.

$4.37 +8.17% $712.56M

Intra-Cellular Therapies, Inc.

$131.87 0.00% $14.05B

Phibro Animal Health Corporation

$55.01 -6.79% $2.23B

Prestige Consumer Healthcare Inc.

$57.57 +1.61% $2.77B

Pacira BioSciences, Inc.

$23.43 -1.35% $1.01B

Procaps Group S.A.

$1.01 +100.00% $102.08M

Regencell Bioscience Holdings Limited

$29.81 -1.00% $14.74B

其他人也在看

Regencell Bioscience Holdings Limited

Intra-Cellular Therapies, Inc.

Prestige Consumer Healthcare Inc.

Phibro Animal Health Corporation

Deciphera Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc.

Collegium Pharmaceutical, Inc.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言